Literature DB >> 22696168

Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.

N Unger1, J Hinrichs, T Deutschbein, H Schmidt, M K Walz, K Mann, S Petersenn.   

Abstract

Adrenal pheochromocytomas are neoplasms characterized by catecholamine excess. Determination of metanephrines by high-pressure liquid chromatography has been well established for the diagnosis of pheochromocytomas, demonstrating high sensitivity and specificity. This study evaluates the diagnostic value of newly available enzyme immunoassays for metanephrines in plasma and urine. Chromogranin A was studied as a potential additional diagnostic tool. Spontaneous blood samples and 24-h urine samples were collected in 149 subjects, including 24 histologically proven pheochromocytomas, 17 aldosterone-secreting and 21 cortisol-secreting adrenal adenomas, 30 nonfunctioning adrenal masses, 15 patients with essential hypertension and 42 healthy normotensive volunteers. Plasma and urinary metanephrine and normetanephrine as well as chromogranin A were determined and putative thresholds were calculated by ROC analysis. Plasma free normetanephrine was found to be the best single parameter with the highest sensitivity (89.5%) and specificity (98.3%) using a threshold of 167 pg/ml. Analysis of the combination of plasma free metanephrines revealed a similar sensitivity with lower specificity of 90.0%. Considering both urinary parameters demonstrated a slightly higher sensitivity (92.9%) with lower specificity (77.6%). ROC analysis revealed a threshold of 215 µg/l for chromogranin A with rather low sensitivity (73.9%) and specificity (74.2%). A weak positive correlation was found between the tumor size of pheochromocytomas and plasma metanephrine (r = 0.53, p ≤ 0.05) as well as chromogranin A (r = 0.60, p ≤ 0.01). In conclusion, plasma free and urinary metanephrines measured by enzyme immunoassays are convenient and reliable parameters for the diagnosis of pheochromocytoma. In contrast, CgA demonstrated poor sensitivity and specificity. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696168     DOI: 10.1055/s-0032-1309007

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  7 in total

Review 1.  Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review.

Authors:  Roland Därr; Matthias Kuhn; Christoph Bode; Stefan R Bornstein; Karel Pacak; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  The importance of standardisation of measurement and reference intervals for detection of phaeochromocytoma and paraganglioma (PPGL).

Authors:  Tomás P Griffin; Delia Bogdanet; Patrick Navin; Grace Callagy; Paula M O'Shea; Marcia Bell
Journal:  Ir J Med Sci       Date:  2018-02-19       Impact factor: 1.568

Review 3.  Recent Trends in the Quantification of Biogenic Amines in Biofluids as Biomarkers of Various Disorders: A Review.

Authors:  Alina Plenis; Ilona Olędzka; Piotr Kowalski; Natalia Miękus; Tomasz Bączek
Journal:  J Clin Med       Date:  2019-05-09       Impact factor: 4.241

4.  PREDICTIVE VALUE OF CHROMOGRANIN A IN A DIAGNOSIS TOWARDS PHEOCHROMOCYTOMA IN ADRENAL INCIDENTALOMA.

Authors:  S K Zawadzka-Leska; M Radziszewski; K Malec; A Stadnik; U Ambroziak
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

5.  Direct electrochemical measurement of metanephrines in spot urine samples for the diagnosis of phaeochromocytomas.

Authors:  Zheng-Hu Shi; Xiao-Qing Zhang; Qian-Na Zhen; Ming Zuo; Gang Tian; Yi-Fan He; Min Ding
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

6.  Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.

Authors:  Eu Jeong Ku; Kyoung Jin Kim; Jung Hee Kim; Mi Kyung Kim; Chang Ho Ahn; Kyung Ae Lee; Seung Hun Lee; You-Bin Lee; Kyeong Hye Park; Yun Mi Choi; Namki Hong; A Ram Hong; Sang-Wook Kang; Byung Kwan Park; Moon-Woo Seong; Myungshin Kim; Kyeong Cheon Jung; Chan Kwon Jung; Young Seok Cho; Jin Chul Paeng; Jae Hyeon Kim; Ohk-Hyun Ryu; Yumie Rhee; Chong Hwa Kim; Eun Jig Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-06

7.  The role of urinary fractionated metanephrines in the diagnosis of phaeochromocytoma.

Authors:  Kanakamani Jeyaraman; Vasanthi Natarajan; Nihal Thomas; Paul Mazhuvanchary Jacob; Aravindan Nair; Nylla Shanthly; Regi Oommen; Gracy Varghese; Fleming Jude Joseph; Mandalam Subramaniam Seshadri; Simon Rajaratnam
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.